Hope springs eternal among policy makers in Europe’s beleaguered periphery. At five minutes to midnight in Athens, and with a bank run having started in Madrid, these policy makers cling to the forlorn hope that somehow Germany is going to relent on its strong opposition to euro bonds.

Roger Scruton, Britain's foremost conservative philosopher, offers a traditionalist manifesto to discomfit both the left and American free-marketeers.

Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.

The Medicaid drug program wasted $329 million nationwide in 2009 from states all too frequently reimbursing for a version of a drug that is more costly than another product with the exact same active ingredient, dose, form and bottle size.

In a just-published op-ed, American Enterprise Institute (AEI) economist Alex Brill sets forth two options to reduce health care costs in Illinois' Medicaid system. If enacted, these efforts would be a part of a broader reform effort which is necessary to avert dramatic cuts in the future.

For all the talk about the Affordable Care Act's mandate to purchase insurance, you might think that the mandate is the linchpin of the entire law. It isn't, at least from the standpoint of whether the insurance market will collapse without it. 

Obamacare may be President Obama proudest legislative achievement, but the fact is it has been a political disaster for Democrats. The unpopular law has galvanized Obama’s conservative opponents, driven away moderates and independents, and hung like an albatross around the neck of the U.S. economy. A decision by the Supreme...

Without profound changes in the scientific and regulatory environment, things will remain very tough for the agile disruptor -- relatively good news for established giants, presumably less good news for patients and for progress.